Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Cell(2021)10.1016/j.cell.2021.03.028Source: DataRank Database

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 is a research paper published in Cell (2021). On theSindex it has a DataRank of 0. It has been cited 1,021 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1,021 citations

Download PDF

Cite:

Linked data & code

gen emdb refseq pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 56.49)OA: bronzeTopics (71)IDs (PubMed, PMC, OpenAlex)Annotations (5)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (34)

Anna De Marco ORCID,Florian A. Lempp ORCID,M. Alejandra Tortorici ORCID,Dora Pinto ORCID,Alexandra C. Walls ORCID

Live enrichment

PubMed:33761326 PMC:PMC7962585 OpenAlex:https://openalex.org/W3136616180

NIAID NIH HHS

Grant: HHSN272201700059C

NIH HHS

Grant: S10 OD023476

NIAID NIH HHS

Grant: DP1 AI158186

NIGMS NIH HHS

Grant: T32 GM008268

NIGMS NIH HHS

Grant: R01 GM120553

National Institutes of Health

Grant: 5DP1AI158186-05

Unraveling the bat humoral immune response against zoonotic viruses to guide the design of next-generation therapeutics

Natural Sciences and Engineering Research Council of Canada

Grant: unidentified

unidentified

National Institutes of Health

Grant: 5R01GM120553-03

Structural Studies of Coronavirus Fusion Proteins

NIGMS

FWCI

56.49

Citation Percentile

1.0%

Citation Trend

2013

2014

2015

2017

2018

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S0092867421003561/pdf

publisherhttp://www.cell.com/article/S0092867421003561/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0092867421003561?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0092867421003561?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cell.2021.03.028

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral Infections and Outbreaks Research0301 basic medicine03 medical and health sciences

MeSH Terms

Protein DomainsCOVID-19SARS-CoV-2AnimalsAntibodies, MonoclonalAntigens, ViralCricetinaeModels, MolecularMutationNeutralization TestsRNA, ViralGenetic VariationEpitope MappingAntibodies, Neutralizing

Keywords

BiologyVirologyEpitopeMonoclonal antibodyAntigenGlycoproteinAntibodyEffectorSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MutationNeutralizationCoronavirus disease 2019 (COVID-19)Cell biologyGeneticsVirusGeneN-terminal domainNeutralizing antibodySpike glycoproteinMemory B CellsNtdCovid-19Sars-cov-2Models, MolecularBiochemistry & Molecular BiologyPROTEINACE2CORONAVIRUSVALIDATIONArticleSTRUCTURAL DEFINITIONProtein DomainsNeutralization TestsCricetinaeCRYO-EM STRUCTUREAnimalsAntigens, Viral11 Medical and Health SciencesScience & TechnologyRECEPTOR-BINDING DOMAINMUTATIONS31 Biological sciencesAntibodies, MonoclonalGenetic VariationMICROSCOPY32 Biomedical and clinical sciences06 Biological SciencesAntibodies, NeutralizingRNA, ViralLife Sciences & BiomedicineEpitope MappingDevelopmental Biology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being